AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED Board/Management Information 2021
61842_rns_2021-03-31_1d7f04dd-bff4-4561-8344-30318eb97d7c.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
March 31, 2021
Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
The BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex
Scrip Code: 541540 Scrip Code: SOLARA
Dear Sirs,
Sub: Outcome of Board Meeting – March 31, 2021. Ref: Regulation 30 of Securities and Exchange - Board of India (Listing Obligation and Disclosure Requirements) Regulations, - 2015
We wish to inform that meeting of Board of Directors of Solara Active Pharma Sciences Limited ("Company") held today (i.e., March 31, 2021), the Directors has inter-alia approved the following:
• Retirement of Mr. S. Hariharan (DIN 05297969) from the position of Executive Director – Finance with effect from March 31, 2021, as per Company's succession plan.
With reference to company's earlier outcome of Board meeting filed with stock exchanges on February 3, 2021, Mr. S. Hariharan, will be succeeded by Mr. Subhash Anand, who was appointed as Executive Director and Chief Financial Officer of the Company with effect from April 1, 2021.
• The Board has approved the allotment of 20,000 equity shares against the Solara Employee Stock Option Plan 2018. Consequent to the said allotment, the paid-up share capital of the Company will increase from Rs. 35,90,97,670 consisting of 3,59,09,767 equity shares of Rs. 10 each to Rs. 35,92,97,670 consisting of 3,59,29,767 equity shares of Rs. 10 each.
We hereby enclose the notification pursuant to Regulation 10(c) of SEBI (Share Based Employee Benefits) Regulations, 2014 and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure "A".
• Grant of options under Solara Employee Stock Option Plan, 2018.
The board has approved grant of ESOP options to following employee under Solara Employee Stock Option Plan, 2018:
| Name | Designation | ESOP grant |
|---|---|---|
| Dr. Sudhir Nambiar | Chief Scientific Officer | 20,000 |
Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
The Board Meeting commenced at 9.00 am and concluded at 10.00 am.
We request you to take the same on record.
Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited
S. Murali Krishna Company Secretary
Encl: As above.
Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
Annexure – A
REGULATION 10 (C ) – NOTIFICATION FOR ISSUE OF SHARES
| S. NO. | PARTICULARS | DETAILS |
|---|---|---|
| 1. | Company name and address of | Solara Active Pharma Sciences Limited |
| registered office | 201, Devavrata, Sector 17, | |
| Vashi, Navi Mumbai – 400703 | ||
| 2. | Name of the Stock Exchange on | 1.NationalStockExchangeofIndia |
| which the company's shares are | Limited | |
| listed | 2.BSE Limited | |
| 3. | Filing date of the statement referred | •NSE: October 24, 2018 |
| in regulation 10(b) of the SEBI | •BSE: October 24, 2018 | |
| (Share Based Employee Benefits) | ||
| Regulations,2014withStockExchange | ||
| 4. | Filing Number, if any | •NSE: NSE/LIST/19224 |
| •BSE: DCS/IPO/JR/ESOP-IP/3352/2018- | ||
| 19 | ||
| 5. | Title of the Scheme pursuant to | Solara Employee Stock Option Plan, 2018 |
| which shares are issued, if any | ||
| 6. | Kind of security to be listed | Equity shares |
| 7. | Par value of the shares | Rs. 10 |
| 8. | Date of issue of shares | March 31, 2021 |
| 9. | Number of shares issued | 20,000 |
| 10 | Share Certificate No., if applicable | Not applicable |
| 11. | Distinctive number of the shares, ifapplicable | 3,59,09,768 - 3,59,29,767 |
| 12. | ISIN Number of the shares if issued | INE624Z01016 |
| in Demat | ||
| 13. | Exercise price per share | Rs. 374 |
| 14. | Premium price per share | Rs. 364 |
| 15. | Total issued shares after this issue | 3,59,29,767 |
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630
Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
| 16. | Total issued share capital after this | Rs. 35,92,97,670 |
|---|---|---|
| issue | ||
| 17. | Details of any lock-in on the shares | NA |
| 18. | Date of expiry of lock-in | NA |
| 19. | Whethersharesidenticalinallrespects to existing shares if not,when will they become identical | Shares issued shall rank pari pasu with theexisting equity shares of the company |
| 20. | Details of listing fees, if payable | NA |
For Solara Active Pharma Sciences Limited
S. Murali Krishna Company Secretary